Showing results (71-80 of 203) with videos related to

Sort By:
Pageof 21
The Oncologist|January 13, 2000
Reality testing in cancer treatment: the phase I trial of endostatinD P Ryan, R T Penson, S Ahmed, et al.
The Oncologist|February 13, 2001
Medical mistakes: a workshop on personal perspectivesR T Penson, S S Svendsen, B A Chabner, et al.
The Journal of Clinical Investigation|August 1, 1982
Synthesis, retention, and biological activity of methotrexate polyglutamates in cultured human breast cancer cellsJ Jolivet, R L Schilsky, B D Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotypeZ Duan, A J Feller, R T Penson, et al.
Experimental Hematology|July 1, 1985
Enrichment of myeloid progenitor cells from normal human bone marrow using an immune-rosette techniqueS Koizumi, R L Fine, G A Curt, et al.
Cancer Research|July 1, 1979
Competitive binding radioassay for 5-fluorodeoxyuridine 5'-monophosphate in tissuesD S Murinson, T Anderson, H S Schwartz, et al.
Cancer Treatment Reports|September 1, 1984
Phase I trial of teroxironeJ A Neidhart, D Derocher, M R Grever, et al.
Cancer Research|December 15, 1991
Production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissueP G Johnston, C M Liang, S Henry, et al.
Annals of Internal Medicine|April 1, 1987
Developmental therapeutics and the acquired immunodeficiency syndromeV T DeVita, S Broder, A S Fauci, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Antifolate metabolism and sites of action: implications for the design of new antifolatesA L Fitzhugh, B A Chabner, P W Sholar, et al.
Pageof 21